← All organizations

Hexal AG

For profit

Also known as: Hexal AG

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jun 14, 2019

Acquired by Novartis on Jan 1, 2005

Timeline

1980s

Jan 1, 1986
Hexal AG— Founded

2000s

Jan 1, 2005
Novartis— Acquired By

Drugs by trial phase (5 distinct, 10 trials)

Phase 4 (1 own, 0 via acquisition)

epoetin

Phase 3 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT03974100CollaboratorPhase 3Jun 14, 2019
NCT02744755CollaboratorPhase 3Mar 1, 2016
NCT02514772CollaboratorPhase 3Jul 1, 2015
NCT02016105CollaboratorPhase 3Dec 1, 2013
NCT01891864CollaboratorPhase 3Jun 1, 2013
NCT00869856Study chairPhase 3Apr 1, 2009
NCT00632125Study chairPhase 4Jul 1, 2008
NCT00632125CollaboratorPhase 4Jul 1, 2008
NCT00701714Study chairPhase 3Sep 1, 2007
NCT00711958Study chairPhase 3Nov 1, 2004
NCT00711958CollaboratorPhase 3Nov 1, 2004
NCT00666835CollaboratorPhase 3Apr 1, 2004

Details

Founded: Holzkirchen, DE Jan 1, 1986
Last known activity: Jun 14, 2019